- GOP outraged Obamacare investigators able to get coverage with fake IDs
- Family removed from Southwest flight over tweet about rude agent, dad says
- Michael Bloomberg thumbs FAA ban, plots course to Israel
- California bans full-contact football practices in off-season
- Thune: Downed fighter jets show more evidence of separatist capabilities
- Obama tells DNC fundraising crowd: ‘I’m not overly partisan’
- Chambliss: Downed jet ultimately goes back to Putin
- Perdue strategy: Run against Reid, Obama, Pelosi
- White House: More changes to contraception mandate coming
- ‘Operation Normandy’ set to send 3,500 volunteers to border to ‘stop an invasion’
Ligand, Glaxo drug gets special FDA designation
Question of the Day
Ligand Pharmaceuticals said Monday that its drug Promacta has received “breakthrough” designation by U.S. regulators for a new use in patients with a rare form of anemia.
Ligand and its partner GlaxoSmithKline already market the pill to treat chronic hepatitis C and a rare condition called chronic immune thrombocytopenic purpura, in which the body attacks its own platelets.
Now the companies are asking the FDA to approve Promacta to treat severe aplastic anemia, a rare condition in which the bone marrow fails to make enough new blood cells. Currently there are no drugs approved for patients who do not respond to existing immune system drugs. About 40 percent of patients in this group die of infection or bleeding within five years of diagnosis, according to the drugmakers.
The FDA’s breakthrough drug program was authorized by Congress in 2012 with the aim of speeding up development of promising medicines. Drugmakers that get the breakthrough designation receive extra meetings and earlier communication with FDA about their applications.
Shares of LaJolla, Calif.-based Ligand Pharmaceuticals Inc. fell $3.64, or 5.9 percent, to $58.30 in afternoon trading as major market indexes slumped. Its shares are up 12 percent over the past three months.
TWT Video Picks
Retailer pays a price for getting too close to Obama
- CARSON: Costco and the perils of mixing politics and business
- House task force to recommend National Guard on border, faster deportations
- Obama orders Pentagon advisers to Ukraine
- Two Ukrainian fighter jets shot down
- HURT: The cost of 'free' water in Detroit
- David Perdue defeats Jack Kingston in Georgia Republican Senate primary runoff
- Beretta moving to Tennessee over Maryland gun laws
- DEACE: How to go from civil rights icon to bigot in one quote
- D.C. appeals panel deals big blow to Obamacare subsidies
- IRS seeks help destroying another 3,200 computer hard drives
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq